Flora Peyvandi/X
Aug 29, 2025, 19:05
Flora Peyvandi: Global Estimates Highlight Treatment of Bleeding Episodes in VWD and Hemophilia A with Desmopressin
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared on X:
”Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A.”
Read the full article here.
Title: Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A
Authors: Alessandro Gringeri, Pier Mannuccio Mannucci, Michele Gringeri, Giancarlo Castaman, Flora Peyvandi
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis